Last updated on June 2018

Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity


Brief description of study

This is a multi-center, randomized, double-blind clinical trial to assess the safety and efficacy of GL-0817 as a means to prevent disease recurrence in patients considered at high-risk following surgery and adjuvant chemoradiotherapy.

Clinical Study Identifier: NCT02873819

Contact Investigators or Research Sites near you

Start Over

Jeffrey Herpst, RN, OCN

Oncology Institute of Vojvodina (IOV), Clinic of Medical Oncology
Sremska Kamenica, Serbia
  Connect »